School of Medicine
Showing 351-360 of 4,927 Results
-
Jill Beyer, OD
Clinical Assistant Professor, Ophthalmology
BioJill Beyer, OD, is a Clinical Assistant Professor at Stanford University School of Medicine.
Dr. Beyer graduated from Southern California College of Optometry, earning her Doctor of Optometry degree with distinction. She completed her residency at New England College of Optometry in Boston, Massachusetts, and earned a Bachelor of Science degree in Biology from Oregon State University.
Jill’s residency education included time spent at the Boston Foundation for Sight, Massachusetts Eye and Ear Infirmary, Cornea Consultants & Boston Laser Center, and Harvard Vanguard Medical Associates.
After residency training, Jill continued on as a clinical preceptor at the New England College of Optometry while working in private practice in Boston. She then transitioned to full time academic work at the Massachusetts Eye and Ear Infirmary becoming the Director of the Contact Lens Department and an Instructor in Ophthalmology at Harvard Medical School. -
Gala Beykin, MD
Clinical Instructor, Ophthalmology
BioDr. Beykin is an ophthalmologist and glaucoma specialist at the Byers Eye Institute at Stanford Health Care. She is also a clinical instructor in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Beykin completed clinical and surgical training in glaucoma at the Byers Eye Institute. She specializes in caring for patients with all types of ophthalmic conditions, including glaucoma and cataract.
She has expertise in clinical trial design and implementation, and studies novel biomarkers and candidate therapeutics for vision protection and restoration in glaucoma. Her research efforts include numerous clinical trials investigating new therapies for eye conditions. Dr. Beykin has participated in multiple studies evaluating drugs targeting retinal disease such as AMD and diabetes-related vision loss, as well as ongoing clinical trials assessing new treatment strategies for neuroprotection, neuroregeneration and neuroenhancement in glaucoma. These include implants that could potentially stop or slow the progression of and help improve vision.
Dr. Beykin has published her work in numerous peer-reviewed journals, including the British Journal of Ophthalmology and Investigative Ophthalmology & Visual Science. She has presented her work at national and international meetings, including those for the International Symposium on Retinal Degeneration and the Association for Research in Vision and Ophthalmology.
She is a member of the Israeli Ophthalmology Society, the Israeli Society for Eye and Vision Research, and the Association for Research in Vision and Ophthalmology. -
Joydeep Bhadury
Instructor, Institute for Stem Cell Biology and Regenerative Medicine
Current Research and Scholarly InterestsMy goal is to generate universally transplantable human organs in research animals.
-
Vivek Bhalla, MD
Associate Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsDr. Bhalla's two primary research interests are in the role of the kidney in diabetes and hypertension. We use molecular, biochemical, and transgenic approaches to study: (1) mechanisms diabetic kidney disease disease including the role of the endothelium to regulate inflammation and kidney injury; and (2) regulation of tubular transport of glucose, sodium, and potassium. These latter studies have treatment implications in diabetes, kidney disease, and hypertension.
-
Rashmi Parekh Bhandari
Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsClinical interventions, treatments, and outcomes in pediatric pain management
-
Sushma Bharadwaj, MD
Clinical Assistant Professor, Medicine - Blood & Marrow Transplantation
BioDr. Bharadwaj is fellowship-trained in blood and marrow transplantation, cellular therapy, hematology, and oncology. She is an instructor in the Stanford School of Medicine Department of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy.
Dr. Bharadwaj focuses her expertise on diagnosing and treating cancer in blood and bone marrow. For each patient, she develops a personalized, comprehensive, and compassionate care plan. In her diverse experience as a physician and scientist, she has served as an internal medicine doctor, hospitalist, hematologist, oncologist, and blood and marrow transplantation specialist. Dr. Bharadwaj has a degree in clinical research and is currently conducting clinical trials in transplant and cellular therapy.
She has participated in research studies of advances in therapy for chronic lymphocytic leukemia, melanoma, and breast cancer. She has co-authored articles published in Leukemia and Lymphoma and elsewhere. Topics include advances in cell transplantation. She also co-wrote the chapter on genome-driven personalized cancer therapy in the book Precision Medicine in Oncology.
Dr. Bharadwaj has made presentations at meetings of the American Society of Hematology, American Society of Clinical Oncology, and other associations.
Subjects include racial, demographic, and socioeconomic disparities in the treatment of patients with acute myeloid leukemia.
Dr. Bharadwaj is a member of the American Society for Transplantation and Cellular Therapy, American Society of Hematology, and American Society of Clinical Oncology. -
Mahendra T. Bhati
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Bhati is an interventional psychiatrist with expertise in psychiatric diagnosis, psychopharmacology, and neuromodulation. He completed postdoctoral research studying language abnormalities and transcranial magnetic stimulation (TMS) evoked potentials in schizophrenia. He was a principal investigator for the DSM-5 academic field trials, and his research experiences included roles as an investigator in the first controlled clinical trials of deep brain stimulation (DBS) and low-field synchronized TMS for treatment of depression. He was the founding Chief of Interventional Psychiatry at Stanford where he performs consultations and provides pharmacological and neuromodulatory treatments. His current research interests include studying magnetic resonance imaging and augmented reality to target TMS, vagus nerve stimulation (VNS) for treatment-resistant depression, DBS for obsessive-compulsive disorder (OCD) and depression, responsive neurostimulation (RNS) for treatment of impulse and fear-related disorders, and focused ultrasound (FUS) for treatment-resistant OCD and depression. Dr. Bhati seeks to train more providers in mental healthcare and founded a clinical fellowship in Interventional Psychiatry at Stanford.
-
Richa Bhatia, MD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Bhatia is a Distinguished Fellow of the American Psychiatric Association and Clinical Associate Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She is a dual Board-certified child, adolescent and adult psychiatrist, specializing in treating anxiety disorders. Her work has been cited in Time magazine and Scientific American, and her professional opinions have been quoted in media such as CNBC, The Guardian, U.S. News and World Report, The Wall Street Journal, CBS News Bay Area, WUCF-TV (PBS), and others. Dr. Bhatia is President-Elect of Northern California Psychiatric Society. She is an avid advocate of improving mental health awareness and reducing the stigma surrounding psychiatric conditions and treatments. For her work in this arena, she was awarded the 2021 Jerilyn Ross Clinician Advocate Award by the Anxiety and Depression Association of America and the Marian Butterfield award by the Association of Women Psychiatrists in 2018. Her other roles include serving as Section Editor for Current Opinion in Psychiatry, a Wolters Kluwer journal, for the last 7 years. She also served as Associate Editor of Current Psychiatry for 6 years. Additionally, she is a Compassion Educator and has received Teacher's Training in Compassion Cultivation Training. She is often invited to give talks at national, regional and local conferences and organizations.
She takes a whole-person approach, utilizing active, empathic listening and aimed at understanding the biological, psychological, social, and other factors affecting an individual’s mental health. She integrates medication management (where needed) with psychotherapy. Her psychotherapy approach is informed by various evidence-based psychotherapies such as psychodynamic therapy, acceptance and commitment therapy, and mindfulness-based, compassion-focused interventions. Dr. Bhatia’s other professional interests include ruling out medical conditions mimicking psychiatric disorders, mindfulness, bullying prevention, and compassion and empathy cultivation.
